Unraveling the role of liver receptor homolog-1 as a regulator of fibroblast activation in Systemic sclerosis
- Weitere Titel
-
Die Rolle des „Liver Receptor Homolog-1“ als Regulator der Fibroblastenaktivierung bei Systemischer Sklerose
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Dissertation, 2023
- Schlagwort
-
Sklerodermie
Signaltransduktion
Pathogenese
Tiermodell
Extrazelluläre Matrix
Lungenfibrose
- Ereignis
-
Veröffentlichung
- (wo)
-
Erlangen
- (wer)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (wann)
-
2023
- Urheber
- Beteiligte Personen und Organisationen
-
Distler, Jörg
Fuhrmann, Gregor
Stürzl, Michael
- URN
-
urn:nbn:de:bvb:29-opus4-225634
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:45 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Chakraborty, Debomita
- Distler, Jörg
- Fuhrmann, Gregor
- Stürzl, Michael
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Entstanden
- 2023
Ähnliche Objekte (12)
S100A4 amplifies TGF-β-induced fibroblast activation in systemic sclerosis
Homolog
Unraveling the connection between fibroblast growth factor and bone morphogenetic protein signaling
Notch signalling regulates fibroblast activation and collagen release in systemic sclerosis
Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis
Impaired TFAM expression promotes mitochondrial damage to drive fibroblast activation and fibrosis in systemic sclerosis
Unraveling DNA
Hedgehog signaling controls fibroblast activation and tissue fibrosis in systemic sclerosis : potential implications for antifibrotic therapies
The role of autophagy and protein tyrosine phosphatase SHP2 in the fibroblast activation in systemic sclerosis
Mechanisms of fibroblast activation and development of novel therapeutic options for the treatment of the systemic sclerosis
Fibroblast growth factor 1 in multiple sclerosis : Localization in brain lesions and effects on cultured human astrocytes
Unraveling Rif1molecular mechanism
S100A4 amplifies TGF-β-induced fibroblast activation in systemic sclerosis
Homolog
Unraveling the connection between fibroblast growth factor and bone morphogenetic protein signaling
Notch signalling regulates fibroblast activation and collagen release in systemic sclerosis
Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis
Impaired TFAM expression promotes mitochondrial damage to drive fibroblast activation and fibrosis in systemic sclerosis
Unraveling DNA
Hedgehog signaling controls fibroblast activation and tissue fibrosis in systemic sclerosis : potential implications for antifibrotic therapies
The role of autophagy and protein tyrosine phosphatase SHP2 in the fibroblast activation in systemic sclerosis
Mechanisms of fibroblast activation and development of novel therapeutic options for the treatment of the systemic sclerosis
Fibroblast growth factor 1 in multiple sclerosis : Localization in brain lesions and effects on cultured human astrocytes
Unraveling Rif1molecular mechanism
S100A4 amplifies TGF-β-induced fibroblast activation in systemic sclerosis
Homolog
Unraveling the connection between fibroblast growth factor and bone morphogenetic protein signaling
Notch signalling regulates fibroblast activation and collagen release in systemic sclerosis
Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis
Impaired TFAM expression promotes mitochondrial damage to drive fibroblast activation and fibrosis in systemic sclerosis
Unraveling DNA
Hedgehog signaling controls fibroblast activation and tissue fibrosis in systemic sclerosis : potential implications for antifibrotic therapies
The role of autophagy and protein tyrosine phosphatase SHP2 in the fibroblast activation in systemic sclerosis
Mechanisms of fibroblast activation and development of novel therapeutic options for the treatment of the systemic sclerosis
Fibroblast growth factor 1 in multiple sclerosis : Localization in brain lesions and effects on cultured human astrocytes